Tumor- derived vesicles as Biomarkers for Ovarian cancer

Withdrawn

• Conditions: Ovarian cancer; 10038594

• Registration Number: NL-OMON37442
• Lead Sponsor: Vrije Universiteit Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

Material from 30 patients diagnosed with ovarian cancer and samples from 30 healthy volunteers will be collected. ;Inclusion criteria for the two groups;1. Patients with ovarian cancer: ;a. Diagnosed with epithelial ovarian cancer
b. > 18 years
c. Treatment in VUMC
d. Understanding of the Dutch or English language
e. Not using any medication
f. No thrombotic events in history
g. Written informed consent ;2. Healthy volunteers: ;a. > 18 years
b. Understanding of the Dutch or English language
c. Not using any medication
d. No malignancies in past
e. No thrombotic events in history
f. Written informed consent

Exclusion Criteria

1. Patients with ovarian cancer: ;a. < 18 years
b. No understanding of the Dutch or English language
c. Patients with history of malignancy other than that of ovarian cancer
d. Use of medication
e. Thrombotic events in history
f. No written informed consent ;2. Healthy volunteers: ;a. < 18 years
b. No understanding of the Dutch or English language
c. Use of medication
d. Malignancies in past
e. Thrombotic events in history
f. No written informed consent

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified